Lilly to open diabetes research center in China

Back to TopCommentsE-mailPrintBookmark and Share

Indianapolis-based Eli Lilly and Co. plans to open a diabetes research center in China, the drugmaker said Tuesday, citing the high incidence of the disease there.

Set to open in Shanghai in the second half of 2011, the research center will focus on discovering new medicines to treat diabetes. Almost 10 percent of adults in China have diabetes, the company said.

“We are establishing this research center, first and foremost, to meet the growing unmet medical needs of those living in China with diabetes," Lilly Research Laboratories President Jan Lundberg said in a prepared statement.

The company did not disclose the costs associated with the new center, but Lilly said it also has committed about $2.5 million over three years to support collaborative diabetes programs between Chinese and European academic centers.

Lilly said its center initially will employ about 100 scientists and support staff, most from China. Shanghai native Bei Betty Zhang, an internationally recognized diabetes expert who received a Ph.D. from Indiana University, will lead the research efforts.

The center’s goal is to discover breakthrough therapies for diabetes as part of Lilly's global diabetes research and development efforts. Drug development is crucial for Lilly, which is facing patent expirations for several best-selling medicines in the next few years.

It has suffered some recent setbacks. Just this month, U.S. regulators unexpectedly delayed the market launch of Lilly’s latest diabetes drug, Bydureon, until the second half of 2012.

Lilly has been building its organization in China. The company has manufacturing facilities in Suzhou and more than sales 30 offices throughout the country, investing more than $300 million there since the early 1990s.

In 2007, it launched a venture capital fund focused on the biopharmaceutical industry in China. Lilly Asian Ventures has made six investments totaling more than $40 million so far, the company said.


  • wakeup
    Opening a research center in China? Don't American companies have any standards any more? Sending research to a country that produced tainted baby formular killing babies in China and resulting in the death of a Chinese official responsible for overseeing such things? I don't trust any research coming from China. This research facility will provide whatever it is desired, wether the data is true or manipulated. I can't imagine how far reaching the effects of such bogus research will be for society. this is scary.

Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. How can any company that has the cash and other assets be allowed to simply foreclose and not pay the debt? Simon, pay the debt and sell the property yourself. Don't just stiff the bank with the loan and require them to find a buyer.

  2. If you only knew....

  3. The proposal is structured in such a way that a private company (who has competitors in the marketplace) has struck a deal to get "financing" through utility ratepayers via IPL. Competitors to BlueIndy are at disadvantage now. The story isn't "how green can we be" but how creative "financing" through captive ratepayers benefits a company whose proposal should sink or float in the competitive marketplace without customer funding. If it was a great idea there would be financing available. IBJ needs to be doing a story on the utility ratemaking piece of this (which is pretty complicated) but instead it suggests that folks are whining about paying for being green.

  4. The facts contained in your post make your position so much more credible than those based on sheer emotion. Thanks for enlightening us.

  5. Please consider a couple of economic realities: First, retail is more consolidated now than it was when malls like this were built. There used to be many department stores. Now, in essence, there is one--Macy's. Right off, you've eliminated the need for multiple anchor stores in malls. And in-line retailers have consolidated or folded or have stopped building new stores because so much of their business is now online. The Limited, for example, Next, malls are closing all over the country, even some of the former gems are now derelict.Times change. And finally, as the income level of any particular area declines, so do the retail offerings. Sad, but true.